WideMed is a leading company in the growing bio-medical signal diagnostics and treatment market. Leveraging its innovative signal processing algorithms, the company offers comprehensive signal analysis and workflow management services and solutions to the fast growing Cardio-Sleep market.
|
Clinical Sleep Information System |
Drug Research Sleep Monitoring |
|
Morpheus® WideMed’s flagship product - the first FDA-approved computer-aided scoring solution. Morpheus is highly recognized by hundreds of physicians around the |
Sleep monitoring has become a standard for sleep disorders drug development. Morpheus provides innovative sleep quality parameters utilizing its advanced spectral analysis technologies enabling pharmaceutical companies a better insight into pharmaceutical effects of drugs. The advanced data management features allow pharmaceutical companies to perform sleep studies while controlling the data base, reducing cost, and enhancing efficiency. |
|
Inpatient Sleep Monitoring |
Cardiovascular Diagnostics & Disease Management |
|
WideMed’s Noga software is an FDA cleared inpatient sleep monitoring and analysis solution that enables the diagnosis of sleep disorders, using a physiological activity monitoring device. By offering inpatient sleep monitoring, WideMed's solution enables sleep study analysis during hospital admission, thus providing additional valuable clinical information on co-morbidity conditions. |
WideMed’s extensive research of physiological signals during sleep has shown that sleep-time is the most appropriate timeframe for patient cardiac evaluation and disease management. WideMed is developing an advanced physiological monitoring solution that will provide cardiovascular diagnostics by a breakthrough marker for Heart Failure (HF) disease monitoring. This innovative solution will enable the enhancement of patient care while reducing treatment costs dramatically. Contact us to learn more |
* Morpheus is a registered trademark of WideMed Ltd.